Chapter 3: Case Studies: EU Regulatory Guidelines and how to interpret them


Author Jun Wang Chancellor Scholar Duke University School of Medicine About the Author Jun Wang is a Chancellor Scholar of Duke University (North Carolina, USA) and a Ph.D candidate majoring in Pharmacology and Cancer Biology. She has strong interest and expertise in two areas of research: using high-throughput screening and next-generation sequencing to identify novel compounds or biologic products that can be effectively deployed for the treatment of invasive solid tumors; and regulatory requirement and methodology development for the assessment of biosimilar products. She combines her biotechnology background with keen interest in the assessment of biosimilar products. She has been...

To view this content, please register now for access

It's completely free